Business Context and Reporting Period
This Form 8-K filing by Ichor Holdings, Ltd. (ICHOR) was submitted on February 13, 2020, reporting events occurring on February 11, 2020. The company is incorporated in the Cayman Islands and trades on the NASDAQ Stock Market. The filing primarily addresses corporate governance changes under Item 5.02 regarding the appointment of new directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figures disclosed relate to director compensation arrangements.
Material Changes
The material change reported is the expansion of the Board of Directors with two new appointments effective February 11, 2020:
- Dr. Wendy Arienzo: Appointed to the Board. She brings extensive experience in semiconductor and materials science, including roles as VP of Operations at Fujifilm Dimatix and former CEO of ArrayPower.
- Jeffrey Andreson: The Company's current Chief Executive Officer was appointed to the Board.
Compensation and Governance Details
Specific compensation terms were disclosed for the new director appointments:
- Dr. Wendy Arienzo: Will receive an annual retainer of $50,000 and a grant of restricted stock units valued at $150,000, vesting over a three-year period based on continued service.
- Jeffrey Andreson: Will not receive any additional compensation for his service on the Board.
- Related Party Transactions: The filing states there are no family relationships or related party transactions requiring disclosure under Item 404(a) of Regulation S-K for either appointee.
Investor Verification Checklist
- Verify the impact of the new board composition on the company's strategic direction, particularly in semiconductor and materials science sectors.
- Confirm the vesting schedule and performance conditions for Dr. Arienzo's restricted stock units in subsequent filings.
- Review the attached press release (Exhibit 99.1) for additional context on the board's rationale for these appointments.
- Note that this filing contains no financial results; investors should refer to the most recent 10-K or 10-Q for financial health metrics.